In vivo dendritic cell reprogramming for cancer immunotherapy

被引：11

作者：

Ascic, Ervin ^{[1
,2
]}

Akerstrom, Fritiof ^{[3
]}

Sreekumar Nair, Malavika ^{[1
,2
]}

Rosa, Andre ^{[3
]}

Kurochkin, Ilia ^{[1
,2
]}

Zimmermannova, Olga ^{[1
,2
]}

Catena, Xavier ^{[1
,2
,3
]}

Rotankova, Nadezhda ^{[4
]}

Veser, Charlotte ^{[4
]}

Rudnik, Michal ^{[4
]}

Ballocci, Tommaso ^{[1
,2
]}

Schaerer, Tiffany ^{[3
]}

Huang, Xiaoli ^{[3
]}

de Rosa Torres, Maria ^{[1
,2
]}

Renaud, Emilie ^{[3
]}

Velasco Santiago, Marta ^{[5
]}

Met, Ozcan ^{[5
,6
]}

Askmyr, David ^{[7
,8
]}

Lindstedt, Malin ^{[9
]}

Greiff, Lennart ^{[7
,8
]}

Ligeon, Laure-Anne ^{[4
]}

Agarkova, Irina ^{[4
]}

Svane, Inge Marie ^{[5
]}

Pires, Cristiana F. ^{[3
]}

Rosa, Fabio F. ^{[3
]}

Pereira, Carlos-Filipe ^{[1
,2
,3
,10
]}

机构：

[1] Lund Univ, Lund Stem Cell Ctr, Mol Med & Gene Therapy, S-22184 Lund, Sweden

[2] Lund Univ, Wallenberg Ctr Mol Med, S-22184 Lund, Sweden

[3] Medicon Village, Asgard Therapeut AB, S-22381 Lund, Sweden

[4] InSphero AG, CH-8952 Schlieren, Switzerland

[5] Copenhagen Univ Hosp, Natl Ctr Canc Immune Therapy CCIT DK, Dept Oncol, DK-2730 Herlev, Denmark

[6] Tech Univ Denmark, Dept Hlth Technol, DK-2800 Kongens Lyngby, Denmark

[7] Skane Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, S-22185 Lund, Sweden

[8] Lund Univ, Dept Clin Sci, S-22184 Lund, Sweden

[9] Lund Univ, Dept Immunotechnol, Medicon Village, S-22381 Lund, Sweden

[10] Univ Coimbra, Ctr Neurosci & Cell Biol, Largo Marques Pombal, P-3004517 Coimbra, Portugal

来源：

SCIENCE | 2024年 / 386卷 / 6719期

基金：

瑞典研究理事会; 欧洲研究理事会;

关键词：

FUNCTIONAL-NEURONS; RESPONSES; ANTIGEN; FIBROBLASTS; CDC1;

D O I：

10.1126/science.adn9083

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Immunotherapy can lead to long-term survival for some cancer patients, yet generalized success has been hampered by insufficient antigen presentation and exclusion of immunogenic cells from the tumor microenvironment. Here, we developed an approach to reprogram tumor cells in vivo by adenoviral delivery of the transcription factors PU.1, IRF8, and BATF3, which enabled them to present antigens as type 1 conventional dendritic cells. Reprogrammed tumor cells remodeled their tumor microenvironment, recruited, and expanded polyclonal cytotoxic T cells; induced tumor regressions; and established long-term systemic immunity in multiple mouse melanoma models. In human tumor spheroids and xenografts, reprogramming to immunogenic dendritic-like cells progressed independently of immunosuppression, which usually limits immunotherapy. Our study paves the way for human clinical trials of in vivo immune cell reprogramming for cancer immunotherapy.

引用

页数：17

共 50 条

[1] Dendritic cell immunotherapy in uterine cancer
Coosemans, An
Tuyaerts, Sandra
Vanderstraeten, Anke
Vergote, Ignace
Amant, Frederic
Van Gool, Stefaan W.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (07) : 1822 - 1827
[2] Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy
Qian, Da
Li, Jialu
Huang, Mingyao
Cui, Qiuxia
Liu, Xiaozhen
Sun, Kailv
BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
[3] Harnessing dendritic cell diversity in cancer immunotherapy
Park, Hae-Young
Ashayeripanah, Mitra
Chopin, Michael
CURRENT OPINION IN IMMUNOLOGY, 2023, 82
[4] Dendritic cell subsets and implications for cancer immunotherapy
Chen, Michael Y.
Zhang, Felicia
Goedegebuure, Simon Peter
Gillanders, William E.
FRONTIERS IN IMMUNOLOGY, 2024, 15
[5] Restoring tumor immunogenicity with dendritic cell reprogramming
Zimmermannova, Olga
Ferreira, Alexandra G.
Ascic, Ervin
Santiago, Marta Velasco
Kurochkin, Ilia
Hansen, Morten
Met, Ozcan
Caiado, Ines
Shapiro, Ilja E.
Michaux, Justine
Humbert, Marion
Soto-Cabrera, Diego
Benonisson, Hreinn
Silverio-Alves, Rita
Gomez-Jimenez, David
Bernardo, Carina
Bauden, Monika
Andersson, Roland
Hoglund, Mattias
Miharada, Kenichi
Nakamura, Yukio
Hugues, Stephanie
Greiff, Lennart
Lindstedt, Malin
Rosa, Fabio F.
Pires, Cristiana F.
Bassani-Sternberg, Michal
Svane, Inge Marie
Pereira, Carlos-Filipe
SCIENCE IMMUNOLOGY, 2023, 8 (85)
[6] Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting
Achmad, Harun
Ibrahim, Yousif Saleh
Al-Taee, Muataz Mohammed
Gabr, Gamal A.
Riaz, Muhammad Waheed
Alshahrani, Shadia Hamoud
Ramirez-Coronel, Andres Alexis
Jalil, Abduladheem Turki
Budi, Hendrik Setia
Sawitri, Windi
Stanislavovna, Malyutina Elena
Gupta, Jitendra
INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
[7] Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
Luo, Shumin
Chen, Jing
Xu, Fang
Chen, Huan
Li, Yiru
Li, Weihua
PHARMACEUTICS, 2023, 15 (08)
[8] CANCER IMMUNOTHERAPY Dendritic-cell vaccines on the move
Sabado, Rachel Lubong
Bhardwaj, Nina
NATURE, 2015, 519 (7543) : 300 - 301
[9] Engineering dendritic cell vaccines to improve cancer immunotherapy
Perez, Caleb R.
De Palma, Michele
NATURE COMMUNICATIONS, 2019, 10 (1)
[10] Dendritic cell-based nanovaccines for cancer immunotherapy
Paulis, Leonie E.
Mandal, Subhra
Kreutz, Martin
Figdor, Carl G.
CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (03) : 389 - 395

← 1 2 3 4 5 →